<DOC>
	<DOCNO>NCT02149199</DOCNO>
	<brief_summary>The purpose study test Symbicort® ( budesonide/formoterol ) Turbuhaler® effective treating asthma use 'as need ' patient milder asthma . The efficacy Symbicort® 'as need ' compare : 1 ) terbutaline Turbuhaler® 'as need ' 2 ) Pulmicort ( budesonide ) Turbuhaler® twice daily plus terbutaline Turbuhaler® 'as need ' .</brief_summary>
	<brief_title>A Clinical Study Evaluate Symbicort Turbuhaler Used 'as Needed ' Adults Adolescents With Asthma .</brief_title>
	<detailed_description>A 52-week , double-blind , randomised , multi-centre , parallel-group , Phase III study patient 12 year old asthma , evaluate efficacy safety Symbicort® ( budesonide/formoterol ) Turbuhaler® 160/4.5 μg 'as need ' compare terbutaline Turbuhaler® 0.4 mg 'as need ' Pulmicort® ( budesonide ) Turbuhaler® 200 μg twice daily plus terbutaline Turbuhaler® 0.4 mg 'as need '</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Terbutaline</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>INCLUSION CRITERIA 1 . Provision inform consent prior study specific procedure . For patient underage , sign informed consent patient patient 's parent/legal guardian require 2 . Male Female , ≥12 year age 3 . Documented diagnosis asthma least 6 month prior Visit 1 4 . Patients need Step 2 treatment accord Global Initiative Asthma guideline 5 . Patients treat 'as need ' inhaled shortacting bronchodilator ( ) prebronchodilator Forced Expiratory Volume one second ( FEV1 ) ≥ 60 % Predicted Normal ( PN ) postbronchodilator FEV1 ≥ 80 % PN 6 . Patients treat low stable dose inhale corticosteroid leukotriene antagonist addition 'as need ' use inhale shortacting bronchodilator ( ) prebronchodilator FEV1 ≥80 % PN 7 . Patients reversible airway obstruction 8 . To randomized patient must use Bricanyl Turbuhaler 'as need ' least 3 separate day last week run period . EXCLUSION CRITERIA 1 . Patient history lifethreatening asthma include intubation intensive care unit admission 2 . Patient asthma worsen require change treatment inhale shortacting bronchodilator ( ) within 30 day prior Visit 1 Visits 1 2 ; treatment Bricanyl Turbuhaler Visit 2 randomization 3 . Patient require treatment oral , rectal parenteral glucocorticosteroids ( GCS ) within 30 day and/or depot parenteral GCS within 12 week prior Visit 1 4 . Smoker ( current previous ) smoke history ≥ 10 pack year 5 . Pregnancy , breastfeed plan pregnancy study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>130 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>